{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T07:26:38Z","timestamp":1787037998426,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00228-026-04139-y","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:11:40Z","timestamp":1783987900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of carvedilol versus metoprolol on ventricular arrhythmia burden and ICD therapies: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0388-3174","authenticated-orcid":false,"given":"Ahmed E.","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9338-9961","authenticated-orcid":false,"given":"Marwan H.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4318-8843","authenticated-orcid":false,"given":"Karim","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6501-6845","authenticated-orcid":false,"given":"Mohamed K.A.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"issue":"2","key":"4139_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.15420\/AER.2016.12.2","volume":"5","author":"A Li","year":"2016","unstructured":"Li A, Kaura A, Sunderland N, Dhillon PS, Scott PA (2016) The Significance of Shocks in Implantable Cardioverter Defibrillator Recipients. Arrhythm Electrophysiol Rev 5(2):110\u2013116","journal-title":"Arrhythm Electrophysiol Rev"},{"issue":"41","key":"4139_CR2","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J et al (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36(41):2793\u20132867","journal-title":"Eur Heart J"},{"issue":"9169","key":"4139_CR3","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"Effect of metoprolol CR\/XL in chronic heart failure","year":"1999","unstructured":"Effect of metoprolol CR\/XL in chronic heart failure (1999) Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353(9169):2001\u20132007","journal-title":"Lancet"},{"issue":"17","key":"4139_CR4","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","volume":"106","author":"M Packer","year":"2002","unstructured":"Packer M, Fowler MB, Roecker EB, Coats AJ, Katus HA, Krum H et al (2002) Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 106(17):2194\u20132199","journal-title":"Circulation"},{"issue":"9377","key":"4139_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","volume":"362","author":"PA Poole-Wilson","year":"2003","unstructured":"Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M et al (2003) Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 362(9377):7\u201313","journal-title":"Lancet"},{"issue":"15","key":"4139_CR6","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.jacc.2013.03.087","volume":"62","author":"MH Ruwald","year":"2013","unstructured":"Ruwald MH, Abu-Zeitone A, Jons C, Ruwald AC, McNitt S, Kutyifa V et al (2013) Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). J Am Coll Cardiol 62(15):1343\u20131350","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"4139_CR7","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.jacep.2023.06.009","volume":"9","author":"A Diamond","year":"2023","unstructured":"Diamond A, Goldenberg I, Younis A, Goldenberg I, Sampath R, Kutyifa V et al (2023) Effect of Carvedilol vs Metoprolol on Atrial and Ventricular Arrhythmias Among Implantable Cardioverter-Defibrillator Recipients. JACC Clin Electrophysiol 9(10):2122\u20132131","journal-title":"JACC Clin Electrophysiol"},{"issue":"2","key":"4139_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/clc.23144","volume":"42","author":"M Ayan","year":"2019","unstructured":"Ayan M, Habash F, Alqam B, Gheith Z, Cross M, Vallurupalli S et al (2019) A comparison of anti-arrhythmic efficacy of carvedilol vs metoprolol succinate in patients with implantable cardioverter-defibrillators. Clin Cardiol 42(2):299\u2013304","journal-title":"Clin Cardiol"},{"key":"4139_CR9","doi-asserted-by":"publisher","unstructured":"Schupp T, Behnes M, Abumayyaleh M, Weidner K, Rusnak J, Mashayekhi K et al (2022) Carvedilol versus metoprolol in patients with ventricular tachyarrhythmias. J Cardiovasc Dev Dis 9(8):274. https:\/\/doi.org\/10.3390\/jcdd9080274Schupp","DOI":"10.3390\/jcdd9080274Schupp"},{"key":"4139_CR10","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"4139_CR11","unstructured":"Chapter 8 Assessing risk of bias in a randomized trial | Cochrane Training"},{"issue":"1","key":"4139_CR12","first-page":"7","volume":"7","author":"LL Ma","year":"2020","unstructured":"Ma LL, Wang YY, Yang ZH, Huang D, Weng H, Zeng XT (2020) Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res 7(1):7","journal-title":"Mil Med Res"},{"issue":"Fi2","key":"4139_CR13","doi-asserted-by":"publisher","first-page":"f217","DOI":"10.1093\/europace\/euy077","volume":"20","author":"AC Ruwald","year":"2018","unstructured":"Ruwald AC, Gislason GH, Vinther M, Johansen JB, Nielsen JC, Philbert BT et al (2018) Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study. Europace 20(Fi2):f217\u2013f24","journal-title":"Europace"},{"issue":"14","key":"4139_CR14","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.jacc.2013.01.020","volume":"61","author":"MH Ruwald","year":"2013","unstructured":"Ruwald MH, Ruwald AC, Jons C, Alexis J, McNitt S, Zareba W et al (2013) Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy). J Am Coll Cardiol 61(14):1518\u20131526","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"4139_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1586\/erc.11.166","volume":"10","author":"JJ DiNicolantonio","year":"2012","unstructured":"DiNicolantonio JJ, Hackam DG (2012) Carvedilol: a third-generation \u03b2-blocker should be a first-choice \u03b2-blocker. Expert Rev Cardiovasc Ther 10(1):13\u201325","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"11","key":"4139_CR16","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1161\/01.CIR.94.11.2817","volume":"94","author":"EM Gilbert","year":"1996","unstructured":"Gilbert EM, Abraham WT, Olsen S, Hattler B, White M, Mealy P et al (1996) Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation 94(11):2817\u20132825","journal-title":"Circulation"},{"issue":"5","key":"4139_CR17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1161\/01.CIR.101.5.558","volume":"101","author":"MR Bristow","year":"2000","unstructured":"Bristow MR (2000) beta-adrenergic receptor blockade in chronic heart failure. Circulation 101(5):558\u2013569","journal-title":"Circulation"},{"issue":"6","key":"4139_CR18","doi-asserted-by":"publisher","first-page":"10d","DOI":"10.1016\/0002-9149(87)90702-8","volume":"60","author":"J Morganroth","year":"1987","unstructured":"Morganroth J (1987) Antiarrhythmic effects of beta-adrenergic blocking agents in benign or potentially lethal ventricular arrhythmias. Am J Cardiol 60(6):10d\u20134d","journal-title":"Am J Cardiol"},{"issue":"4","key":"4139_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/clc.4960280403","volume":"28","author":"GV Naccarelli","year":"2005","unstructured":"Naccarelli GV, Lukas MA (2005) Carvedilol\u2019s antiarrhythmic properties: therapeutic implications in patients with left ventricular dysfunction. Clin Cardiol 28(4):165\u2013173","journal-title":"Clin Cardiol"},{"issue":"5","key":"4139_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10557-005-4761-9","volume":"19","author":"T Kohno","year":"2005","unstructured":"Kohno T, Yoshikawa T, Yoshizawa A, Nakamura I, Anzai T, Satoh T et al (2005) Carvedilol exerts more potent antiadrenergic effect than metoprolol in heart failure. Cardiovasc Drugs Ther 19(5):347\u2013355","journal-title":"Cardiovasc Drugs Ther"},{"issue":"8","key":"4139_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4330\/wjc.v12.i8.373","volume":"12","author":"JA Borovac","year":"2020","unstructured":"Borovac JA, D\u2019Amario D, Bozic J, Glavas D (2020) Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers. World J Cardiol 12(8):373\u2013408","journal-title":"World J Cardiol"},{"issue":"9","key":"4139_CR22","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.hrthm.2007.04.022","volume":"4","author":"M Haghjoo","year":"2007","unstructured":"Haghjoo M, Saravi M, Hashemi MJ, Hosseini S, Givtaj N, Ghafarinejad MH et al (2007) Optimal beta-blocker for prevention of atrial fibrillation after on-pump coronary artery bypass graft surgery: carvedilol versus metoprolol. Heart Rhythm 4(9):1170\u20131174","journal-title":"Heart Rhythm"},{"issue":"2","key":"4139_CR23","doi-asserted-by":"publisher","first-page":"102220","DOI":"10.1016\/j.cpcardiol.2023.102220","volume":"49","author":"MR Abouzid","year":"2024","unstructured":"Abouzid MR, Vyas A, Eldahtoury S, Anwar J, Naccour S, Elshafei S et al (2024) Which should you choose for post operative atrial fibrillation, carvedilol or metoprolol? A systemic review and meta-analysis. Curr Probl Cardiol 49(2):102220","journal-title":"Curr Probl Cardiol"},{"issue":"10","key":"4139_CR24","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1001\/jamainternmed.2014.3258","volume":"174","author":"B Pasternak","year":"2014","unstructured":"Pasternak B, Svanstr\u00f6m H, Melbye M, Hviid A (2014) Association of treatment with carvedilol vs metoprolol succinate and mortality in patients with heart failure. JAMA Intern Med 174(10):1597\u20131604","journal-title":"JAMA Intern Med"},{"issue":"10","key":"4139_CR25","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.amjmed.2014.05.032","volume":"127","author":"S Bangalore","year":"2014","unstructured":"Bangalore S, Makani H, Radford M, Thakur K, Toklu B, Katz SD et al (2014) Clinical outcomes with \u03b2-blockers for myocardial infarction: a meta-analysis of randomized trials. Am J Med 127(10):939\u2013953","journal-title":"Am J Med"},{"key":"4139_CR26","unstructured":"Comparative effectiveness of carvedilol versus metoprolol succinate in heart failure patients with an implantable cardioverter defibrillator (CARVTOP-ICD). ClinicalTrials.gov identifier: NCT06964464. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06964464"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04139-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04139-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04139-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:55:28Z","timestamp":1787036128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04139-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4139"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04139-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"25 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. As a systematic review and metaanalysis, this study did not require clinical trial registration the review protocol was prospectively registered in PROSPERO (CRD42024567046).","order":4,"name":"Ethics","label":"Clinical trial registration","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"206"}}